Boulder, CO, United States of America

Neboisa Janjic


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neboisa Janjic: Innovator in Oligonucleotide Ligands

Introduction

Neboisa Janjic is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the development of high-affinity oligonucleotide ligands.

Latest Patents

Neboisa Janjic holds a patent for "High affinity oligonucleotide ligands to growth factors." This invention describes methods for identifying and preparing high-affinity nucleic acid ligands to TGFβ, PDGF, and hKGF. The patent includes specific RNA and ssDNA ligands to TGFβ1 and PDGF identified by the SELEX method. Additionally, it features RNA ligands that inhibit the interaction of TGFβ1 and hKGF with their receptors, as well as DNA ligands that inhibit the interaction of PDGF with its receptor. He has 1 patent to his name.

Career Highlights

Neboisa Janjic is currently associated with Nexstar Pharmaceuticals, Inc., where he continues to advance his research and innovations in the field. His work has the potential to impact therapeutic approaches significantly.

Collaborations

He has collaborated with esteemed colleagues such as Larry M Gold and Nikos C Pagratis, contributing to a rich environment of innovation and research.

Conclusion

Neboisa Janjic's work in the development of oligonucleotide ligands showcases his commitment to advancing biotechnology. His contributions are paving the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…